Position in ZTS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,971,770
+$2,346,068 QoQ
Shares Held
41,355
+731.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#423
of 1,408 holders
Holding Since
Dec 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AXQ CAPITAL, LP holds $9,179,081 across 16 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (32.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
41,355 | $2,971,770 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
50,448 | $1,241,525 | |
| 3 | VTRS |
Viatris Inc
|
76,086 | $1,208,245 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
23,376 | $959,117 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
12,095 | $571,730 | |
| 6 | LQDA |
Liquidia Corp
|
6,846 | $545,831 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
54,534 | $545,340 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
9,572 | $242,841 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,971,770 | 41,355 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $625,702 | 4,973 | Shares | Sole | 2026-02-10 | |
| 2025-03-31 | $567,713 | 3,448 | Shares | Sole | 2025-05-13 | |
| 2024-03-31 | $1,505,969 | 8,900 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,164,483 | 5,900 | Shares | Sole | 2024-02-13 | |
| 2022-12-31 | $481,563 | 3,286 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||